[{"NetIncomeLoss_1_Q3_USD":-22597000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"LiabilitiesNoncurrent_0_Q3_USD":4374000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":-29000.0,"RestrictedCashCurrent_0_Q3_USD":147000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-22000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":48700000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-88223000.0,"Depreciation_3_Q3_USD":739000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1250947.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":36759319.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":84000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":22000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_3_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":2608000.0,"AssetsCurrent_0_Q3_USD":244933000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":73000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":2532000.0,"UnrecognizedTaxBenefits_0_Q3_USD":0.0,"CommonStockSharesIssued_0_Q3_shares":36780393.0,"Assets_0_Q3_USD":253771000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":44000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":36706647.0,"GeneralAndAdministrativeExpense_1_Q3_USD":8325000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":23173000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":38366000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":14358000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":7801000.0,"ProceedsFromStockPlans_3_Q3_USD":509000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":98000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":42000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"CommonStockValue_0_Q3_USD":4000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":-707000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":1113000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":1000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-61379000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-22577000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":3496000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":149038000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":3915000.0,"Liabilities_0_Q3_USD":16258000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-22000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":20000.0,"OperatingLeaseLiability_0_Q3_USD":5340000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-22000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":364000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":20000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":5326000.0,"CommonStockSharesOutstanding_0_Q3_shares":36780393.0,"RestrictedCashNoncurrent_0_Q3_USD":569000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":87226000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":4614000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-50649000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":2124000.0,"LiabilitiesCurrent_0_Q3_USD":11884000.0,"AccountsPayableCurrent_0_Q3_USD":655000.0,"NonoperatingIncomeExpense_3_Q3_USD":182000.0,"DeferredFinanceCostsCurrentNet_0_Q3_USD":117000.0,"NonoperatingIncomeExpense_1_Q3_USD":86000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":605000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":28000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.0414,"AdditionalPaidInCapital_0_Q3_USD":409166000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":149754000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":334000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":38000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2943000.0,"NetIncomeLoss_3_Q3_USD":-61357000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":8468000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-137759000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-171635000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":87140000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"InterestReceivableCurrent_0_Q3_USD":45000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":519000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":173000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2073000.0,"CommonStockSharesAuthorized_0_Q3_shares":300000000.0,"OperatingIncomeLoss_3_Q3_USD":-61539000.0,"OperatingIncomeLoss_1_Q3_USD":-22683000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":87118000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":253771000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":11764000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":4614000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1425000.0,"OperatingExpenses_3_Q3_USD":61539000.0,"OperatingExpenses_1_Q3_USD":22683000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.67,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.61,"ProfitLoss_3_Q3_USD":-61357000.0,"OtherLiabilitiesCurrent_0_Q3_USD":328000.0,"StockholdersEquity_0_Q3_USD":237513000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":997000.0,"ShareBasedCompensation_3_Q3_USD":11764000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":518000.0,"Ticker":"STOK","CIK":"1623526","name":"STOKE THERAPEUTICS, INC.","OfficialName":"Stoke Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"702726891.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211108"}]